Metraipolis › archive › dc_76ffbc3ea0a7

US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO — Europe PMC PMID:42213502

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42213502
DOI
10.2196/101884
License (as archived)
solo-consultazione
Archived
2026-11-01T03:59:51.154Z
SHA-256 of the archived text
5f5b3c254f5f9e1f9db3bd7a38f58bbebc53b7559a8107c9ee4c5fb78fb98b0b
Stable URL of this page
https://metraipolis.com/documento/dc_76ffbc3ea0a7

How to cite

US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO — Europe PMC PMID:42213502 — Europe PMC (en), https://europepmc.org/article/MED/42213502 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76ffbc3ea0a7 (Metraipolis archive dc_76ffbc3ea0a7, sha256 5f5b3c254f5f9e1f9db3bd7a38f58bbebc53b7559a8107c9ee4c5fb78fb98b0b)
BibTeX
@misc{dc76ffbc3ea0a7,
  title = {US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO — Europe PMC PMID:42213502},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42213502},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76ffbc3ea0a7; sha256 5f5b3c254f5f9e1f9db3bd7a38f58bbebc53b7559a8107c9ee4c5fb78fb98b0b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42213502. Agents can read the archived copy with the MCP tool read_document.